First, the low platelet counts associated with reduced prothrombin availability (mean 100,000 platelets/μL) markedly exceed the levels (<20,000 platelets/μL) associated with hemorrhagic disease in LCMV-infected, platelet-depleted mice (28). This evidence concerns the gene F2 and hemorrhagic disease.